Maplight Therapeutics, Inc. · NASDAQ:MPLT

Lillie James Woodruff sold 18,267 Maplight Therapeutics, Inc. shares (Form 4)

Traded Jul 15 to Jul 17, 2026 · Filed Jul 17, 2026

From Jul 15 to Jul 17, 2026, Lillie James Woodruff (Chief Scientific Officer) sold 18,267 Maplight Therapeutics, Inc. shares at an average US$36.88 for US$674K, leaving 224,462 shares. Filed Jul 17, 2026 (Form 4).

Sold
18,267 shares
Price
US$36.88 average (US$36.00 to US$37.96)
Value
US$674K
Holding after
224,462 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Voting Common StockSale2,238US$36.00240,491Direct
Jul 15, 2026Voting Common StockSale5,393US$36.99235,098Direct
Jul 15, 2026Voting Common StockSale12US$37.54235,086Direct
Jul 16, 2026Voting Common StockSale5,009US$36.45230,077Direct
Jul 16, 2026Voting Common StockSale3,526US$37.26226,551Direct
Jul 16, 2026Voting Common StockSale12US$37.96226,539Direct
Jul 17, 2026Voting Common StockSale2,077US$37.90224,462Direct

Source

View original at SEC

Related